Bausch Health Companies Inc. (BHC) — Financial statements
Income statement, balance sheet, and cash flow for Bausch Health Companies Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 10,446↑8.5% | 9,625↑9.9% | 8,757↑7.8% | 8,124↓3.7% | 8,434 | |
| Cost of Revenue | 4,084↑46.8% | 2,782↑8.7% | 2,559↑8.2% | 2,364↓1.3% | 2,394 | |
| Gross Profit | 6,361↓7.0% | 6,843↑10.4% | 6,198↑7.6% | 5,760↓4.6% | 6,040 | |
| Operating Expenses | ||||||
| R&D Expenses | 640↑0.9% | 634↑5.0% | 604↑14.0% | 530↑12.1% | 473 | |
| General & Administrative Expenses | 0.00↓100.0% | 2,497↑10.0% | 2,270↑12.8% | 2,013↑1.8% | 1,977 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 786↑25.8% | 625↑20.7% | 518↑0.6% | 515 | |
| SG&A Expenses | 3,498↑6.6% | 3,283↑13.4% | 2,895↑14.4% | 2,531↑1.6% | 2,492 | |
| Other Expenses | 0.00↓100.0% | 1,380↓20.5% | 1,736↓22.7% | 2,245↓14.5% | 2,625 | |
| Operating Expenses | 4,138↓21.9% | 5,297↑1.2% | 5,235↓1.3% | 5,306↓5.1% | 5,590 | |
| Total Costs & Expenses | 8,222↑1.8% | 8,079↑3.7% | 7,794↑1.6% | 7,670↓3.9% | 7,984 | |
| Operating Results | ||||||
| Operating Income | 2,223↑43.8% | 1,546↑60.5% | 963↑112.1% | 454↑0.9% | 450 | |
| Depreciation & Amortization | 1,229↓3.0% | 1,267↑0.2% | 1,264↓9.3% | 1,394↓10.2% | 1,552 | |
| EBITDA | 3,452↑10.2% | 3,134↑8.6% | 2,885↑0.2% | 2,878↓11.7% | 3,260 | |
| EBIT | 2,223↑19.1% | 1,867↑15.2% | 1,621↑9.2% | 1,484↓13.1% | 1,708 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1,593↓17.6% | -1,355↓4.1% | -1,302↑10.2% | -1,450↓2.2% | -1,419 | |
| Interest Income | 49↑48.0% | 33↑26.9% | 26↑85.7% | 14↑100.0% | 7 | |
| Interest Expense | 1,642↑18.3% | 1,388↑4.5% | 1,328↓9.3% | 1,464↑2.7% | 1,426 | |
| Non-Operating Income | 0.00↑100.0% | -321↑51.2% | -658↑36.1% | -1,030↑18.1% | -1,258 | |
| Other Income / Expenses | -1,850↓34.1% | -1,379↓1.9% | -1,353↓132.1% | -583↑60.4% | -1,474 | |
| Income Before Tax | 373↑123.6% | 167↑142.8% | -390↓202.3% | -129↑87.4% | -1,024 | |
| Income Tax Expense | 251↑5.2% | 239↑8.1% | 221↑166.3% | 83↑195.4% | -87 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 122↑269.6% | -72↑88.2% | -611↓188.2% | -212↑77.4% | -937 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 160↑447.3% | -46↑92.2% | -592↓163.1% | -225↑76.3% | -948 | |
| Bottom-Line Net Income | 160↑447.3% | -46↑92.2% | -592↓163.1% | -225↑76.3% | -948 | |
| EPS (Basic) | 0.43↑430.8% | -0.13↑92.0% | -1.62↓161.3% | -0.62↑76.2% | -2.61 | |
| EPS (Diluted) | 0.43↑430.8% | -0.13↑92.0% | -1.62↓161.3% | -0.62↑76.2% | -2.61 | |
| Weighted Average Shares | 371↑0.8% | 368↑0.7% | 365↑0.9% | 362↑0.9% | 359 | |
| Weighted Average Diluted Shares | 375↑1.9% | 368↑0.8% | 365↑0.8% | 362↑0.9% | 359 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.